Development of a Topical Containing a Non-Coding Oligonucleotide
Time: 9:45 am
day: Day Two
Details:
• Proof-of-concept study in canines with atopic dermatitis
• Cutaneous CD11b+ cells that inhibit Th1/2/9 responses and promote Tregs are recruited by a non-coding oligonucleotide
• Upregulation of immune-checkpoint proteins on cutaneous CD11b+ cells
